Immunovant (IMVT) Financials: Revenue & Earnings

IMVT price $29.03 +0.15 +0.52%

Ticker
IMVT
Price
$29.03
Change
+0.15 +0.52%
Market cap ?
$6.00B
P/E ?
-9.99
Forward P/E ?
205.26
Dividend yield ?
0.00%
Beta ?
0.84
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
62
Value
55
Quality
39
Growth
92

Stocklytics score rationale: value 55, quality 39, growth 92.

Financials

201820192020202120222023202420252026
000000000

Immunovant, Inc. is a biopharmaceutical firm in the clinical development phase, dedicated to advancing novel monoclonal antibody therapies for the treatment of various autoimmune conditions. The company's primary focus is batoclimab, a pioneering, fully human monoclonal antibody. This antibody is engineered to specifically target and block the neonatal fragment crystallizable receptor (FcRn), a key mechanism in…

Fair value

IMVT fair value Not meaningful. Price $29.03.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Not meaningful. The model is more than 80% below the live price, which happens for unprofitable or very early companies and is not a price target.

Compare IMVT

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-09—-0.74—7.09M
2026-08-06-0.75-0.637.09M7.09M
2026-05-20-0.73-0.59——
2026-02-06-0.61-0.72—6.00M
2025-11-10-0.73-0.72——
2025-08-11-0.60-0.69——
2025-05-29-0.64-0.71——
2025-02-06-0.76-0.73——
2024-11-07-0.74-0.61——
2024-08-06-0.60-0.53——
2024-05-29-0.52-0.43——
2024-02-12-0.36-0.43——
2023-11-09-0.45-0.47——
2023-08-10-0.57-0.45——
2023-05-22-0.46-0.43——
2023-02-03-0.49-0.39——
2022-11-04-0.41-0.39——
2022-08-05-0.35-0.40——
2022-06-08-0.41-0.38——
2022-02-04-0.36-0.33——
2021-11-05-0.35-0.28——
2021-08-09-0.31-0.31——
2021-06-01-0.29-0.33——
2021-02-16-0.32-0.26——
2020-11-12-0.25-0.34——
2020-08-12-0.38-0.33——
2020-06-29-0.38-0.53——
2020-02-14-0.28-0.25——
2019-11-060.00———
2019-08-120.06———
2019-06-12-0.00———
2018-12-31-0.24———
2018-09-30-0.36———
2018-06-30-0.44———

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-10-21Stout Jay SSell2.60K$28.9475.10K
2026-10-07Stout Jay SSell2.21K$32.0670.95K
2026-10-07Stout Jay SSell1.60K$32.0651.17K
2026-10-07Van Tuyl ChristopherSell1.33K$32.0642.54K
2026-10-07Gloria MelanieSell2.24K$32.0671.85K
2026-10-02Venker EricSell3.51K$34.11119.59K
2026-10-01Venker EricSell92.19K$14.461.33M
2026-10-01Venker EricBuy92.19K$14.461.33M
2026-10-01Venker EricSell85.89K$33.652.89M
2026-09-23Van Tuyl ChristopherSell2.85K$36.36103.48K
2026-08-28Pande AtulBuy1.50K$8.4312.64K
2026-08-28Pande AtulSell1.50K$43.2764.91K
2026-08-28Pande AtulSell1.50K$8.4312.64K
2026-08-20Gloria MelanieSell3.06K$44.16134.95K
2026-07-24Pande AtulBuy1.50K$8.4312.64K
2026-07-24Pande AtulSell1.50K$39.8059.70K
2026-07-24Pande AtulSell1.50K$8.4312.64K
2026-07-23Girao TiagoSell6.80K$38.69263.01K
2026-07-23Stout Jay SSell2.86K$38.69110.54K
2026-07-08Gloria MelanieSell1.93K$39.5376.29K
2026-07-08Gloria MelanieSell106$39.994.24K
2026-07-08Van Tuyl ChristopherSell1.14K$39.5345.18K
2026-07-08Van Tuyl ChristopherSell63$39.992.52K
2026-07-08Stout Jay SSell1.91K$39.5375.34K
2026-07-08Stout Jay SSell105$39.994.20K
2026-07-08Stout Jay SSell1.40K$39.5355.30K
2026-07-08Stout Jay SSell77$39.993.08K
2026-07-02Venker EricSell3.09K$38.48118.98K
2026-07-01Venker EricSell92.19K$14.461.33M
2026-07-01Venker EricBuy92.19K$14.461.33M
2026-07-01Venker EricSell86.63K$38.143.30M
2026-06-26Gloria MelanieSell14.75K$38.18563.08K
2026-06-26Gloria MelanieSell2.97K$38.95115.53K
2026-06-26Stout Jay SSell33.28K$38.181.27M
2026-06-26Stout Jay SSell6.72K$38.94261.79K
2026-06-26Van Tuyl ChristopherBuy17.82K$15.20270.92K
2026-06-26Van Tuyl ChristopherSell14.98K$38.19572.16K
2026-06-26Van Tuyl ChristopherSell2.84K$38.96110.72K
2026-06-26Van Tuyl ChristopherSell17.82K$15.20270.92K
2026-06-26Girao TiagoSell10.00K$15.90159.00K
2026-06-26Girao TiagoBuy10.00K$15.90159.00K
2026-06-26Girao TiagoSell10.00K$38.46384.60K
2026-06-26Pande AtulBuy1.50K$8.4312.64K
2026-06-26Pande AtulSell1.50K$38.0157.02K
2026-06-26Pande AtulSell1.50K$8.4312.64K
2026-06-18Van Tuyl ChristopherSell2.63K$35.3993.22K
2026-06-15Pande AtulBuy1.50K$8.4312.64K
2026-06-15Pande AtulSell1.50K$34.0251.03K
2026-06-15Pande AtulSell1.50K$8.4312.64K
2026-05-28Fromkin Andrew J.Buy16.26K$14.70239.02K
2026-05-28Fromkin Andrew J.Sell11.48K$32.64374.81K
2026-05-28Fromkin Andrew J.Buy77.18K$8.43650.64K
2026-05-28Fromkin Andrew J.Buy71.49K$7.94567.65K
2026-05-28Fromkin Andrew J.Buy31.67K$4.99158.02K
2026-05-28Fromkin Andrew J.Sell210.47K$33.567.06M
2026-05-28Fromkin Andrew J.Sell31.67K$4.99158.02K
2026-05-28Fromkin Andrew J.Sell71.49K$7.94567.65K
2026-05-28Fromkin Andrew J.Sell77.18K$8.43650.64K
2026-05-28Fromkin Andrew J.Sell16.26K$14.70239.02K
2026-05-20Gloria MelanieSell249$30.417.57K
2026-05-20Gloria MelanieSell1.17K$32.1537.55K
2026-05-20Gloria MelanieSell1.70K$32.9555.95K
2026-05-20Pande AtulSell6.00K$8.4350.58K
2026-05-20Pande AtulBuy6.00K$8.4350.58K
2026-05-20Pande AtulSell6.00K$32.00192.00K
2026-05-01Susman Robert GrahamSell2.50K$27.1767.98K
2026-04-23Girao TiagoSell25.76K$29.62763.01K
2026-04-23Stout Jay SSell2.75K$29.6281.57K
2026-04-08Van Tuyl ChristopherSell5.17K$24.83128.25K
2026-04-08Gloria MelanieSell8.72K$24.83216.57K
2026-04-08Stout Jay SSell8.61K$24.83213.89K
2026-04-08Stout Jay SSell1.52K$24.8337.69K
2026-04-07Torti FrankBuy174.19K——
2026-04-07Torti FrankBuy88.33K$24.612.17M
2026-04-07Fromkin Andrew J.Buy13.88K——
2026-04-07Fromkin Andrew J.Buy7.06K$24.61173.77K
2026-04-07Hughes Douglas J.Buy13.88K——
2026-04-07Hughes Douglas J.Buy7.06K$24.61173.77K
2026-04-07Pande AtulBuy13.88K——
2026-04-07Pande AtulBuy7.06K$24.61173.77K
2026-04-07Bauer JakeBuy13.88K——
2026-04-07Bauer JakeBuy7.06K$24.61173.77K
2026-04-07Susman Robert GrahamBuy13.88K——
2026-04-07Susman Robert GrahamBuy7.06K$24.61173.77K
2026-04-07Gloria MelanieBuy83.67K——
2026-04-07Gloria MelanieBuy121.06K$24.612.98M
2026-04-07Stout Jay SBuy66.94K——
2026-04-07Stout Jay SBuy96.85K$24.612.38M
2026-04-07Van Tuyl ChristopherBuy41.34K——
2026-04-07Van Tuyl ChristopherBuy59.82K$24.611.47M
2026-04-07Venker EricBuy336.04K$24.618.27M
2026-04-07Venker EricBuy232.25K——
2026-04-07Girao TiagoBuy64.97K——
2026-04-07Girao TiagoBuy94.00K$24.612.31M
2026-04-02Venker EricSell12.82K$24.04308.19K
2026-04-02Venker EricSell1.41K$24.6034.66K
2026-04-01Venker EricSell368.75K$14.465.33M
2026-04-01Venker EricBuy368.75K$14.465.33M
2026-04-01Venker EricSell334.96K$25.108.41M
2026-03-18Van Tuyl ChristopherSell2.88K$24.9771.84K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 240, holders +13 vs prior quarter. Ownership 54.04%.

HolderSharesChangeChange %Value
FMR LLC16.19M-761.42K-4.49%623.66M
DEEP TRACK CAPITAL, LP9.34M-2.19M-18.96%359.91M
BLACKROCK, INC.7.18M606.40K+9.22%276.68M
FARALLON CAPITAL MANAGEMENT, L.L.C.5.80M4.26M+275.49%223.67M
BAKER BROS. ADVISORS LP5.44M-22.66K-0.42%209.42M
STATE STREET CORP4.62M79.08K+1.74%177.89M
MORGAN STANLEY4.53M657.96K+16.97%174.73M
TCG CROSSOVER MANAGEMENT, LLC4.46M00.00%171.77M
VANGUARD PORTFOLIO MANAGEMENT LLC3.91M205.60K+5.55%150.67M
VANGUARD CAPITAL MANAGEMENT LLC3.64M18.63K+0.51%140.20M
JENNISON ASSOCIATES LLC3.31M113.53K+3.55%127.54M
RTW INVESTMENTS, LP3.18M00.00%122.44M
TWO SEAS CAPITAL LP3.15M-53.46K-1.67%121.31M
ADAR1 CAPITAL MANAGEMENT, LLC2.33M-348.29K-13.00%89.80M
GEODE CAPITAL MANAGEMENT, LLC2.23M142.50K+6.81%86.12M
T. ROWE PRICE INVESTMENT MANAGEMENT, INC.2.22M-1.39M-38.49%85.62M
WOODLINE PARTNERS LP1.98M00.00%76.13M
PRICE T ROWE ASSOCIATES INC /MD/1.83M1.49M+438.63%70.48M
GOLDMAN SACHS GROUP INC1.75M-33.92K-1.90%67.47M
ARMISTICE CAPITAL, LLC1.74M-164.00K-8.63%66.89M
ALPINE GLOBAL MANAGEMENT, LLC1.38M-1.26M-47.86%52.98M
PERCEPTIVE ADVISORS LLC1.36M-240.00K-15.02%52.30M
D. E. SHAW & CO., INC.1.24M1.24MNew47.80M
ARMISTICE CAPITAL, LLC1.20M-700.00K-36.84%46.24M
BANK OF AMERICA CORP /DE/1.18M287.77K+32.20%45.52M

Earnings and financials

Immunovant, Inc. (IMVT) trades at $29.03, with a market cap of $6.00B and a trailing P/E of -9.99. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

201820192020202120222023202420252026
000000000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Immunovant (IMVT) Financials: Revenue & Earnings

IMVT$29.03+0.15 +0.52%

$6.00B

Market Cap

-9.99

P/E

205.26

Forward P/E

62

Score

Price History